Skip to Content

Arrayit Corp ARYC

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ARYC is trading at a 37% discount.
Price
$0.00
Fair Value
$4.19
Uncertainty
Extreme
1-Star Price
$5.61
5-Star Price
$2.50
Economic Moat
Yxx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ARYC is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.03 / $0.03
Market Cap
$1,126.50
Volume/Avg
140,000 / 75,500

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Arrayit Corp is a developer, manufacturer, and marketer of next-generation life science tools and integrated systems for the large-scale analysis of genetic variation, biological function, and diagnostics. Using its proprietary and patented technologies, it provides a comprehensive line of products and services that currently serve the sequencing, genotyping, and protein analysis markets. In addition, it also provides tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Its products include microarrayers, buffers, microarray instruments, printing, substrate slides, software and others. The operations of the firm are carried out through the region of US.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
7

Valuation

Metric
ARYC
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
ARYC
Quick Ratio
0.03
Current Ratio
0.10
Interest Coverage
−9.19
Quick Ratio
ARYC

Profitability

Metric
ARYC
Return on Assets (Normalized)
−202.71%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
ARYC
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
TMO
Thermo Fisher Scientific IncDhbnhtnwVplk$215.8 Bil
DHR
Danaher CorpGvyyblypVfmrxv$177.7 Bil
IQV
IQVIA Holdings IncMrrtlsvYpfzxws$42.6 Bil
A
Agilent Technologies IncKtvzpgbnbPsbs$42.2 Bil
IDXX
IDEXX Laboratories IncQrdlklkqlGtphsp$41.3 Bil
MTD
Mettler-Toledo International IncYtmbbgwbvqVnlbqd$27.0 Bil
ICLR
Icon PLCXdrxbqctWfsczw$25.8 Bil
ILMN
Illumina IncCbtqdylNhngqm$20.2 Bil
WAT
Waters CorpQzzrtwxzvtJxyy$19.1 Bil
LH
Laboratory Corp of America HoldingsHpzbfcdyxpNkxbd$17.4 Bil

Sponsor Center